Cuff and calm: new combo aims to boost heart health

NCT ID NCT07514624

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a blood-pressure cuff device (called chronic remote ischemic conditioning) along with mindfulness audio sessions can improve blood flow to the heart in people with coronary artery disease who couldn't have all blockages opened. About 480 adults with chest pain and partially treated arteries will be randomly assigned to the combo treatment or a control. The main goal is to see if heart blood flow improves after 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

chronic remote ischemic conditioning (a device that squeezes the arm with a blood-pressure cuff) and mindfulness therapy (guided audio sessions)

What this could lead to

If it works, this could offer a non-drug way to improve heart blood flow and reduce chest pain or heart events in people with partially treated coronary artery disease.

What could go wrong

This trial hasn't started yet, and it's a Phase NA study with 480 participants. The combination approach is new, so benefits are uncertain, and the device may cause discomfort or bruising.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••